Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver tumor and
remains a fatal malignancy in the majority of patients. Approximately 20%–30% of patients …

Objective: To review the current management, outline recent advances and address
controversies in the management of hepatocellular carcinoma (HCC). Summary of …

Patients with pancreatic and biliary carcinomas lack personalized treatment options, in part
because biopsies are often inadequate for molecular characterization. Cell-free DNA …

Abstract The TheraSphere Global Dosimetry Steering Committee was formed in 2017 by
BTG International to review existing data and address gaps in knowledge related to …

Background Gallbladder cancer is rare, but cancers detected incidentally after
cholecystectomy are increasing. The aim of this study was to review the available data for …

Objectives This study was conducted in order to establish and validate a radiomics model for
predicting lymph node (LN) metastasis of intrahepatic cholangiocarcinoma (IHC) and to …

Cholangiocarcinoma (CCC) is the most aggressive malignant tumor of the biliary tract.
Perihilar CCC (pCCC) is the most common CCC and is burdened by a complicated …

Purpose To compare the efficacy of stereotactic ablative radiation therapy (SABR) versus
liver resection for small hepatocellular carcinoma (HCC)≤ 5 cm with Child-Pugh A cirrhosis …

The prevalence of hepatocellular carcinoma (HCC) worldwide parallels that of persistent
infection with the hepatitis B virus (HBV) and/or hepatitis C virus (HCV). According to …

Radioembolization of Hepatic Malignancies: Background, Quality Improvement Guidelines, and
Future Directions. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …